#stat plus

[meret118]

Study: To be cost-effective, Gilead's new HIV pill needs near-50% price cut

“We agree Descovy has a different, albeit improved safety profile ... but how much more should we be willing to pay?” asked one study author.

[kenacks]

The cost of some cancer drugs doesn't line up with the benefit

A new study finds higher cancer drug prices aren''t correlated with better clinical benefits. The paper also found prices are particularly high in the U.S.

[rygeraci-blog]

Machine learning will yield new drug candidates within three years - STAT

What defines modern machine learning is its ability to pick out insights from massive data sets that humans will never be able to see.

This article talks about how machine learning will soon help find the perfect candidates for drug testing.  This could drastically change how pharmaceutical companies conduct trials and research

[inspirecommunity]

Akouos seeks a way to treat a gene-based hearing loss - STAT

Akouos, is trying to develop the first gene therapy to treat hearing loss — in particular, a form of deafness caused by mutations in a single gene.

[icareforcaregivers]

Drug industry tries to press Congress to lift burden for more drug costs

Pharma's latest ad campaign warns of a looming "cliff" for Medicare beneficiaries. But the industry is campaigning on a separate issue as well.

[monohedron]

[monohedron]

[monohedron]